BridgeMD
New treatment option for Pancreatic Cancer Resectable
Official title The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
ClinicalTrials.gov ID: NCT06368063
What this study is testing
What is Huaier granule?
Huaier granule is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for pancreatic cancer resectable.
Also referred to as Z20000109#NMPA Approval Number#.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study is a multicenter, prospective clinical study aimed at evaluating the efficacy and safety of Huaier Granule in postoperative adjuvant treatment of resectable pancreatic cancer
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age range from 18 to 80 years old, regardless of gender;
- Pancreatic cancer was diagnosed by histopathology after radical surgery within 12 weeks before enrollment;
- Did not receive neoadjuvant therapy before surgery and did not receive any adjuvant therapy after surgery;
- ECOG score 0-3 points;
- Those who choose to use standard chemotherapy independently based on their own situation, or choose Huaier granules for subsequent treatment...
You likely can't join if
- Known to be allergic to the components of Huaier granules or to avoid or use Huai er granules with caution (Huaier group);
- Difficulties in taking oral medication due to active gastrointestinal bleeding, perforation, gastric paralysis, etc;
- Suffering from serious mental illness or other reasons that the researcher deems unsuitable to participate in this study.
- History of merging with other malignant tumors;
- Patients with concomitant myocardial infarction, cerebral infarction, and other thromboembolic diseases requiring surgical treatment;
- Concomitant severe infection;
See the full eligibility criteria
- Age range from 18 to 80 years old, regardless of gender;
- Pancreatic cancer was diagnosed by histopathology after radical surgery within 12 weeks before enrollment;
- Did not receive neoadjuvant therapy before surgery and did not receive any adjuvant therapy after surgery;
- ECOG score 0-3 points;
- Those who choose to use standard chemotherapy independently based on their own situation, or choose Huaier granules for subsequent treatment, voluntarily participate in and cooperate with various research work...
- The people voluntarily signed a written informed consent form before participating in this study.
- Known to be allergic to the components of Huaier granules or to avoid or use Huai er granules with caution (Huaier group);
- Difficulties in taking oral medication due to active gastrointestinal bleeding, perforation, gastric paralysis, etc;
- Suffering from serious mental illness or other reasons that the researcher deems unsuitable to participate in this study.
- History of merging with other malignant tumors;
- Patients with concomitant myocardial infarction, cerebral infarction, and other thromboembolic diseases requiring surgical treatment;
- Concomitant severe infection;
- Child Pugh C-grade liver function, renal function 2-5 grades (glomerular filtration rate\<90ml/min);
- Pregnant or lactating women or those planning to conceive;
- The patient has received other traditional Chinese patent medicines and simple preparations with anti-tumor effect, chemotherapy or physical therapy in the past 4 weeks(including but not limited to compound cantharidin...
The study team makes the final eligibility decision.
Where it's taking place
- Xi'an, Shannxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xi'an, Shannxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.